Health News: [cancer]

Sponsored Link Special Offer - Free Trial of Blockbuster.com Rent Movies from Blockbuster.com. Delivered Direct To Your Mailbox. Click here to start today. ---------------------------------------------------------------------------------------------------------- Wednesday, October 17, 2012 10:57 AM PDT Your Health News Alert for [cancer] matched the following stories: Associated Press via Yahoo! News, Wed, 17 Oct 2012 08:10 AM PDT Study: Multivitamins may lower cancer risk in men http://news.yahoo.com/study-multivitamins-may-lower-cancer-risk-men-143404710.html America's favorite dietary supplements, multivitamins, modestly lowered the risk for cancer in healthy male doctors who took them for more than a decade, the first large study to test these pills has found. Good Morning America via Yahoo! News, Wed, 17 Oct 2012 07:50 AM PDT Multivitamins Cut Cancer Risk in Men http://news.yahoo.com/multivitamins-cut-cancer-risk-men-145014509--abc-news-health.html Supplement Fills Nutritional Gaps Reuters via Yahoo! News, Wed, 17 Oct 2012 07:44 AM PDT UPDATE 2-Armstrong steps down from charity; Nike drops sponsorship http://news.yahoo.com/1-armstrong-steps-down-charity-nike-drops-sponsorship-125540902--sector.html * Armstrong to remain on board of Livestrong * Foundation's finances not affected by doping scandal, documents show * Nike withdraws support, cites "seemingly insurmountable evidence" AUSTIN, Texas, Oct 17 (Reuters) - Lance Armstrong on Wednesday stepped down as chairman of the charity he founded to distance the cancer patient-support organization from the widening doping scandal that promises ... Reuters via Yahoo! Singapore News, Wed, 17 Oct 2012 07:37 AM PDT Daily multivitamin shown to help ward off cancer in men http://sg.news.yahoo.com/daily-multivitamin-shown-help-ward-off-cancer-men-143756148.html LOS ANGELES (Reuters) - Swallowing a daily multivitamin can reduce the risk of cancer by at least eight percent in middle-aged and older men and appears to have no dangerous side-effects, according to the first large-scale, randomized study on the subject. The protective effect of the daily pill was described as "modest" by the trial investigators who emphasized that the primary use of vitamins ... The Canadian Press via Yahoo! Canada News, Wed, 17 Oct 2012 07:34 AM PDT Multivitamins modestly lowered the risk of cancer in middle-aged and older men, study finds http://ca.news.yahoo.com/multivitamins-modestly-lowered-risk-cancer-middle-aged-older-143400878.html America's favourite dietary supplements, multivitamins, modestly lowered the risk for cancer in healthy male doctors who took them for more than a decade, the first large study to test these pills has found. The Florida Times-Union, Wed, 17 Oct 2012 03:55 AM PDT The changing picture of breast cancer http://jacksonville.com/news/health-and-fitness/2012-10-17/story/changing-picture-breast-cancer Breast cancer remains a medical and social challenge, as well as a major public health problem. More than 1.1 million women are diagnosed with breast cancer each year worldwide and more than 410,000 of them die from this disease. Reuters via Yahoo! News, Wed, 17 Oct 2012 03:22 AM PDT Pfizer kidney cancer drug fails as initial treatment http://news.yahoo.com/pfizer-kidney-cancer-drug-fails-initial-treatment-102226813--finance.html (Reuters) - Pfizer Inc said its kidney cancer drug did not meet the main goal of showing a statistically significant improvement in survival in a late-stage trial without the cancer getting worse. The trial was testing the drug Inlyta in patients who have received no prior treatments and compared its effects with another kidney cancer drug, sorafenib. Inlyta is already approved to treat kidney ... Reuters via Yahoo! Canada News, Tue, 16 Oct 2012 11:53 AM PDT FDA reviewers spot safety concerns with Sanofi, Isis lipid drug http://ca.news.yahoo.com/fda-reviewers-spot-safety-concerns-sanofi-isis-lipid-185302130.html (Reuters) - U.S. drug reviewers flagged several safety concerns, including possible cancer risks, related to Sanofi SA and Isis Pharmaceuticals Inc's lipid disorder drug Kynamro, sending Isis's shares down as much as 21 percent. In briefing documents posted on the regulator's website on Tuesday, U.S. Food and Drug Administration reviewers said patients taking the drug had a high drop-out rate ... See more health stories that match your keyword at: http://search.news.yahoo.com/search/news/?fr=yalerts-health&c=&p=cancer+%2bcat%3ahealth&ei=utf-8 Visit Yahoo! Health: http://health.yahoo.com/ You received this email because you subscribed to Yahoo! Alerts. Use http://us.rd.yahoo.com/alerts/b/email/unsubscribe/*http://alerts.yahoo.com/unsubscribe.php?id=gjacB5guNLNNqw32aXfWIKJe4NS6hk74CTuZnWv.2b8qLehAq3SPXGT1VTobL5gZq1GPuwKIELIp6T5J1OnWI2T42_9c7XMGhFJK to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences: http://login.yahoo.com/config/login_verify2?.done=http://subscribe.yahoo.com/showaccount . To learn more about Yahoo!'s use of personal information, please read our privacy policy at http://privacy.yahoo.com/privacy/us/ . Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.